Khalid El Bairi: It was a true pleasure to present at OncoVision2025
Khalid El Bairi, Founder of The Cancer Biomarkers Working Group, shared a post on LinkedIn:
“It was a true pleasure to present at OncoVision2025, organized by the Department of Medical Oncology at Mohammed VI University Hospital in Marrakech under the leadership of Prof. Rhizlane Belbaraka. Prof. Belbaraka is making significant efforts to create opportunities for young oncologists and researchers to grow.
My talk focused on flawed designs in the current translational oncology landscape, offering a critical review of methodological issues present in many phase III trials.
This opportunity would not have been possible without the invaluable training we received from Prof. Ian Tannock, who continues to do outstanding work in teaching medical professionals to critically evaluate flawed clinical trials in oncology.”
More posts featuring Khalid El Bairi.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023